Laura G. Eichorn
Founder at IMAGO BIOSCIENCES, INC.
Profile
Laura G.
Eichorn is the founder and currently serves as the Chief Financial Officer at Imago BioSciences, Inc., a company she founded in 2012.
She previously worked as the Vice President-Operations & Finance at FerroKin BioSciences, Inc. Ms. Eichorn obtained her undergraduate degree from Frostburg State University.
Laura G. Eichorn active positions
Companies | Position | Start |
---|---|---|
IMAGO BIOSCIENCES, INC. | Founder | 2012-02-29 |
Former positions of Laura G. Eichorn
Companies | Position | End |
---|---|---|
FerroKin BioSciences, Inc.
FerroKin BioSciences, Inc. Pharmaceuticals: MajorHealth Technology FerroKin BioSciences, Inc. offers clinical stage biotechnology services for iron chelator in the treatment of iron-overload in patients with transfusion-dependent hereditary and acquired refractory anemia. The company was founded by Hugh Young Rienhoff, Jr. in 2007 and is headquartered in San Carlos, CA. | Director of Finance/CFO | - |
Training of Laura G. Eichorn
Frostburg State University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
FerroKin BioSciences, Inc.
FerroKin BioSciences, Inc. Pharmaceuticals: MajorHealth Technology FerroKin BioSciences, Inc. offers clinical stage biotechnology services for iron chelator in the treatment of iron-overload in patients with transfusion-dependent hereditary and acquired refractory anemia. The company was founded by Hugh Young Rienhoff, Jr. in 2007 and is headquartered in San Carlos, CA. | Health Technology |
Imago BioSciences, Inc.
Imago BioSciences, Inc. BiotechnologyHealth Technology Imago BioSciences, Inc. operates as a clinical-stage biopharmaceutical company that develops novel anti-cancer therapeutics. It translates science of genetics and epigenetics enzymes into novel medicines for treating myeloid diseases that pose challenges to patients, families, and physicians. The company also translates insights into transformative therapies that alter the history of disease allowing patients to live longer and disease-free lives. Imago BioSciences was founded by Hugh Young Rienhoff, Jr., Laura G. Eichorn and Jennifer Peppe on March 29, 2012 and is headquartered in Redwood City, CA. | Health Technology |
- Stock Market
- Insiders
- Laura G. Eichorn